表紙
市場調査レポート

世界の疼痛管理治療薬市場

Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

発行 GBI Research 商品コード 224307
出版日 ページ情報 英文 186 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
世界の疼痛管理治療薬市場 Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
出版日: 2013年07月10日 ページ情報: 英文 186 Pages
概要

当レポートでは、世界の疼痛管理治療薬市場について調査分析し、市場の動向と予測、欧米・日本などの地域別の動向、最終段階の薬剤プロファイル、市場参入企業の競合動向などについて検証して、概略以下の構成でお届けいたします。

第1章 目次

第2章 疼痛管理治療薬市場:イントロダクション

第3章 疼痛管理治療薬市場:市場概要

  • イントロダクション
  • WHO除痛ラダー
  • リスク評価・リスク緩和戦略(REMS)
  • 収益
  • 主な市販の疼痛管理薬
  • 年間治療費
  • 治療の利用パターン
  • 疼痛管理治療薬市場における促進要因・抑制要因

第4章 疼痛管理治療薬市場:治療環境

  • 線維筋痛
  • 神経因性疼痛
  • 片頭痛
  • 癌性疼痛
  • 変形性関節症の痛み
  • 関節リウマチの痛み
  • 腰痛
  • 術後疼痛

第5章 疼痛管理治療薬市場:地域別環境

  • 米国
  • 欧州主要5ヶ国
  • 日本

第6章 疼痛管理治療薬市場:アジア太平洋地域および中国

第7章 疼痛管理治療薬市場:パイプライン分析

  • イントロダクション
  • 疼痛管理治療薬市場における最終段階の薬剤プロファイル

第8章 疼痛管理治療薬市場:競合環境

  • 競合プロファイリング

第9章 疼痛管理治療薬市場:戦略的統合

  • 概要
  • 研究開発ライセンス契約
  • 共同開発取引

第10章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GBIHC300MR

Summary

GBI Research's report "Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline" provides insights and analysis into the market. Pain is a widespread problem across the world. More than 25% of the total population suffers from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its management presents a considerable challenge for physicians. Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage these pain-related problems accurately. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In many cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results. This is primarily due to the absence of a perfect pain management solution. Pain management can be most effective only when the underlying disease conditions are cured. However, there is no treatment that offers absolute relief for the indications covered in this report. The medications given for these indications are more for modifying the disease symptoms than offering complete relief from pain. The combination of under-managed pain, low awareness, and fear of addiction to some classes of pain medication is preventing people suffering pain from seeking treatment 100% of the time.

Scope

  • Overview of the pain management market by analyzing the revenue, Annual Cost of Therapy (ACT) and treatment usage pattern across the top seven markets, which are the US, the UK, France, Germany, Spain, Italy and Japan.
  • Therapeutic landscape of the pain management therapeutics market and includes detailed market sizing and analysis of the trends in eight indications, which are fibromyalgia, neuropathic pain, cancer pain, Osteoarthritis (OA) pain, Rheumatoid Arthritis (RA) pain, migraine, Low Back Pain (LBP) and post-operative pain.
  • Geographical landscape of the pain management therapeutics market in the top seven markets, which are the US, the UK, France, Germany, Spain, Italy and Japan.
  • Detailed pipeline analysis of the pain management market (as of April 2013). The section also contains detailed analyses of the most promising pipeline molecules.
  • Profiles of the top companies operating in the pain management therapeutics market.
  • List of strategic consolidations, such as M&A deals, licensing agreements and partnership deals that took place in the global pain management therapeutics market between 2007 and 2013.

Reasons to buy

  • Align your product portfolio to the markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
  • Devise a more tailored country strategy through the understanding of key drivers and barriers of the region's pain management therapeutics market.
  • Develop key strategic initiatives by understanding the key focus areas and top selling pain management therapeutics molecules of leading companies.
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Executive Summary

Rapid Cancer Pain Management Growth to Push Global Revenue to $7 Billion by 2019.

The cancer pain management market is expected to be the fastest growing segment within the global pain management therapeutics market, achieving sales of $7 billion by 2019, according to new analysis from business intelligence firm GBI Research.

The new report* states that the cancer pain management market will increase at a Compound Annual Growth Rate (CAGR) of 9.1% from 2012 to 2019, followed closely by the post-operative market boasting an estimated increase of 8% over the forecast period.

It will also become the second largest segment of the overall pain management market, claiming 15%, while the neuropathic pain management market will continue to hold the largest share of 16%.

According to GBI Research, the growth of the cancer pain management sector will be driven by the increasing global prevalence of cancer, with drugs such as Fenota, Nucynta, Remoxy and Abstral leading the market.

(Quote: Something including the number of people suffering with cancer pain globally / how much this is expected to increase by / the current unmet needs in the market.)

The significant growth of this treatment area will help boost the growth of the overall pain management market, which GBI Research estimates will rise from $36 billion in 2012 to $49 billion in 2019, representing a CAGR of 4.6%.

A healthy pipeline will also contribute to climbing market revenue, with neuropathic pain being the key therapy area of R&D focus, followed by migraine pain, which currently claims 14% of the pipeline.

Despite this level of activity, the overall pain management market will be prevented from growing any further due to the challenges posed by generic competition, which is expected to increase over the coming years following a series of patent expiries for top-selling drugs such as Cymbalta, Lyrica and Celebrex (celecoxib).

However, GBI Research anticipates pain management therapeutics to remain attractive over the forecast period, thanks to its significant potential for expansion in the long term and current unmet needs in the market.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Pain Management Therapeutics Market to 2019 - Introduction

3. Pain Management Therapeutics Market to 2019 - Market Overview

  • 3.1. Introduction
  • 3.2. World Health Organization Pain Ladder
  • 3.3. Risk Evaluation and Mitigation Strategy
  • 3.4. Revenue
  • 3.5. Major Marketed Pain Management Drugs
    • 3.5.1. Abstral (fentanyl citrate)
    • 3.5.2. Celebrex (celecoxib)
    • 3.5.3. Cymbalta (duloxetine)
    • 3.5.4. Exparel (Bupivacaine ER)
    • 3.5.5. Lidoderm (lidocaine patch)
    • 3.5.6. Lyrica (pregabalin)
    • 3.5.7. Nucynta ER (tapentadol ER)
    • 3.5.8. Qutenza (capsaicin)
    • 3.5.9. Savella (milnacipran hydrochloride)
    • 3.5.10. Vimovo (esomeprazole magnesium + naproxen)
    • 3.5.11. Voltaren Gel (diclofenac sodium)
  • 3.6. Annual Cost of Therapy
  • 3.7. Treatment Usage Patterns
    • 3.7.1. Prevalence Population
    • 3.7.2. Diagnosed Population
    • 3.7.3. Prescription Population
  • 3.8. Drivers and Restraints of the Pain Management Therapeutics Market
    • 3.8.1. Drivers
    • 3.8.2. Restraints

4. Pain Management Therapeutics Market to 2019 - Therapeutic Landscape

  • 4.1. Pain Management Therapeutics Market for Fibromyalgia
    • 4.1.1. Introduction
    • 4.1.2. Revenue
    • 4.1.3. Annual Cost of Therapy
    • 4.1.4. Treatment Flow Algorithm
    • 4.1.5. Treatment Usage Pattern
    • 4.1.6. Geographical Segmentation
    • 4.1.7. Drivers and Restraints for the Fibromyalgia Market
    • 4.1.8. Drivers
    • 4.1.9. Restraints for the Fibromyalgia Pain Relief Market
  • 4.2. Pain Management Therapeutics for Neuropathic Pain
    • 4.2.1. Introduction
    • 4.2.2. Revenue
    • 4.2.3. Annual Cost of Therapy
    • 4.2.4. Treatment Flow Algorithm
    • 4.2.5. Treatment Usage Pattern
    • 4.2.6. Geographical Segmentation
    • 4.2.7. Drivers and Restraints for the Neuropathic Pain Market
    • 4.2.8. Drivers
    • 4.2.9. Restraints
  • 4.3. Pain Management Therapeutics Market for Migraine
    • 4.3.1. Introduction
    • 4.3.2. Revenue
    • 4.3.3. Annual Cost of Therapy
    • 4.3.4. Treatment Flow Algorithm
    • 4.3.5. Treatment Usage Pattern
    • 4.3.6. Geographical Segmentation
    • 4.3.7. Drivers and Restraints for the Migraine Market
    • 4.3.8. Drivers
    • 4.3.9. Restraints
  • 4.4. Pain Management Therapeutics Market for Cancer Pain
    • 4.4.1. Introduction
    • 4.4.2. Revenue
    • 4.4.3. Annual Cost of Therapy
    • 4.4.4. Treatment Flow Algorithm
    • 4.4.5. Treatment Usage Pattern
    • 4.4.6. Geographical Segmentation
    • 4.4.7. Drivers and Restraints for the Cancer Pain Market
    • 4.4.8. Drivers
    • 4.4.9. Restraints
  • 4.5. Pain Management Therapeutics Market for Osteoarthritis Pain
    • 4.5.1. Introduction
    • 4.5.2. Revenue
    • 4.5.3. Annual Cost of Therapy
    • 4.5.4. Treatment Flow Algorithm
    • 4.5.5. Treatment Usage Pattern
    • 4.5.6. Geographical Segmentation
    • 4.5.7. Drivers and Restraints for the Osteoarthritis Pain Market
    • 4.5.8. Drivers
    • 4.5.9. Restraints
  • 4.6. Pain Management Therapeutics Market for Rheumatoid Arthritis Pain
    • 4.6.1. Introduction
    • 4.6.2. Revenue
    • 4.6.3. Annual Cost of Therapy
    • 4.6.4. Treatment Flow Algorithm
    • 4.6.5. Treatment Usage Pattern
    • 4.6.6. Geographical Segmentation
    • 4.6.7. Drivers and Restraints for the Rheumatoid Arthritis Market
    • 4.6.8. Drivers
    • 4.6.9. Restraints
  • 4.7. Pain Management Therapeutics Market for Low Back Pain
    • 4.7.1. Introduction
    • 4.7.2. Revenue
    • 4.7.3. Annual Cost of Therapy
    • 4.7.4. Treatment Flow Algorithm
    • 4.7.5. Treatment Usage Pattern
    • 4.7.6. Geographical Segmentation
    • 4.7.7. Drivers and Restraints for the Low Back Pain Market
    • 4.7.8. Drivers
    • 4.7.9. Restraints
  • 4.8. Pain Management Therapeutics Market for Post-operative Pain
    • 4.8.1. Introduction
    • 4.8.2. Revenue
    • 4.8.3. Annual Cost of Therapy
    • 4.8.4. Treatment Flow Algorithm
    • 4.8.5. Treatment Usage Pattern
    • 4.8.6. Geographical Segmentation
    • 4.8.7. Drivers and Restraints for the Post-operative Pain Market
    • 4.8.8. Drivers
    • 4.8.9. Restraints

5. Pain Management Therapeutics Market to 2019 - Geographical Landscape

  • 5.1. The US
    • 5.1.1. Revenue
    • 5.1.2. Annual Cost of Therapy
    • 5.1.3. Treatment Usage Pattern
  • 5.2. Top Five European Countries
    • 5.2.1. Revenue
    • 5.2.2. Annual Cost of Therapy
    • 5.2.3. Treatment Usage Pattern
  • 5.3. Japan
    • 5.3.1. Revenue
    • 5.3.2. Annual Cost of Therapy
    • 5.3.3. Treatment Usage Pattern

6. Pain Management Therapeutics Market to 2019 - Asia-Pacific and China

  • 6.1. India
    • 6.1.1. Regulatory Landscape
    • 6.1.2. Marketed Products
    • 6.1.3. Company Profiling
  • 6.2. China
    • 6.2.1. Regulatory Landscape
    • 6.2.2. Marketed Products
    • 6.2.3. Company Profiling
  • 6.3. Australia
    • 6.3.1. Regulatory Landscape
    • 6.3.2. Marketed Products
    • 6.3.3. Company Profiling

7. Pain Management Therapeutics Market to 2019 - Pipeline Analysis

  • 7.1. Introduction
    • 7.1.1. Research and Development Pipeline - Fibromyalgia
    • 7.1.2. Research and Development Pipeline - Neuropathic Pain
    • 7.1.3. Research and Development Pipeline - Migraine
    • 7.1.4. Research and Development Pipeline - Cancer Pain
    • 7.1.5. Research and Development Pipeline - Osteoarthritis Pain
    • 7.1.6. Research and Development Pipeline - Low Back Pain
    • 7.1.7. Research and Development Pipeline - Post-operative Pain
  • 7.2. Profiles of Key Late-Stage Drugs in the Pain Management Therapeutics Market
    • 7.2.1. AmiKet
    • 7.2.2. Civanex
    • 7.2.3. Droxidopa
    • 7.2.4. Posidur
    • 7.2.5. Sativex
    • 7.2.6. TNX-102
    • 7.2.7. Tetrodotoxin

8. Pain Management Therapeutics Market to 2019 - Competitive Landscape

  • 8.1. Pfizer Inc
    • 8.1.1. Overview
    • 8.1.2. Product Profile
  • 8.2. Johnson & Johnson
    • 8.2.1. Overview
    • 8.2.2. Product Portfolio
  • 8.3. Endo Pharmaceuticals
    • 8.3.1. Overview
    • 8.3.2. Product Portfolio
  • 8.4. Forest Laboratories
    • 8.4.1. Overview
    • 8.4.2. Product Portfolio
  • 8.5. Eli Lilly
    • 8.5.1. Overview
    • 8.5.2. Product Portfolio
  • 8.6. Teva Pharmaceuticals (Cephalon, Inc.)
    • 8.6.1. Overview
    • 8.6.2. Product Portfolio
  • 8.7. Purdue Pharma
    • 8.7.1. Overview
    • 8.7.2. Product Portfolio

9. Pain Management Therapeutics Market to 2019 - Strategic Consolidations

  • 9.1. Overview
    • 9.1.1. M&A Deals by Year
    • 9.1.2. M&A Deals by Indication
    • 9.1.3. Recent Deals
  • 9.2. Licensing Agreements
    • 9.2.1. Deals by Year
    • 9.2.2. Deals by Indication
    • 9.2.3. Deals by Phase
    • 9.2.4. Recent Licensing Deals
  • 9.3. Partnership Deals
    • 9.3.1. Deals by Year
    • 9.3.2. Deals by Indication
    • 9.3.3. Recent Partnership Deals

10. Management Therapeutics Market to 2019 - Appendix

  • 10.1. Market Definitions
  • 10.2. Abbreviations
  • 10.3. Bibliography
  • 10.4. Research Methodology
    • 10.4.1. Coverage
    • 10.4.2. Secondary Research
    • 10.4.3. Primary Research
  • 10.5. Therapeutic Landscape
    • 10.5.1. Market
  • 10.6. Geographical Landscape
  • 10.7. Pipeline Analysis
  • 10.8. Competitive Landscape
    • 10.8.1. Expert Panel Validation
  • 10.9. Contact Us
  • 10.10. Disclaimer

List of Tables

  • Table 1: Pain Management Therapeutics Market, Top Seven Markets, Revenue ($bn), 2006-2012
  • Table 2: Pain Management Therapeutics Market, Top Seven Markets, Revenue Forecast ($bn), 2012-2019
  • Table 3: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2006-2012
  • Table 4: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 5: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (million), 2006-2012
  • Table 6: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 7: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue ($bn), 2006-2012
  • Table 8: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue Forecast ($bn), 2012-2019
  • Table 9: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy ($), 2006-2012
  • Table 10: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 11: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern (Million), 2006-2012
  • Table 12: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern Forecast (Million), 2012-2019
  • Table 13: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue ($bn), 2006-2012
  • Table 14: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue Forecast ($bn), 2012-2019
  • Table 15: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy ($), 2006-2012
  • Table 16: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 17: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern (million), 2006-2012
  • Table 18: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 19: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue ($bn), 2006-2012
  • Table 20: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue Forecast ($bn), 2012-2019
  • Table 21: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy ($), 2006-2012
  • Table 22: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 23: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern (million), 2006-2012
  • Table 24: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 25: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue ($bn), 2006-2012
  • Table 26: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue Forecast ($bn), 2012-2019
  • Table 27: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy ($), 2006-2012
  • Table 28: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy Forecast ($), 2012-2019e
  • Table 29: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern (million), 2006-2012
  • Table 30: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 31: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue ($bn), 2006-2012
  • Table 32: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue Forecast ($bn), 2012-2019
  • Table 33: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy ($), 2006-2012
  • Table 34: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 35: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern (million), 2006-2012
  • Table 36: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 37: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue ($bn), 2006-2012
  • Table 38: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue Forecast ($bn), 2012-2019
  • Table 39: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy ($'000), 2006-2012
  • Table 40: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy Forecast ($'000), 2012-2019
  • Table 41: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Treatment Usage Pattern (million), 2006-2012
  • Table 42: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 43: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Revenue ($bn), 2006-2012
  • Table 44: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Revenue Forecast ($bn), 2012-2019
  • Table 45: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Annual Cost of Therapy ($), 2006-2012
  • Table 46: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 47: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Treatment Usage Pattern (million), 2006-2012
  • Table 48: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 49: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Revenue ($bn), 2006-2012
  • Table 50: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Revenue Forecast ($bn), 2012-2019
  • Table 51: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Annual Cost of Therapy ($), 2006-2012
  • Table 52: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 53: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Treatment Usage Pattern Forecast (million), 2006-2012
  • Table 54: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 55: Pain Management Therapeutics Market, US, Revenue ($bn), 2006-2012
  • Table 56: Pain Management Therapeutics Market, US, Revenue Forecast ($bn), 2012-2019
  • Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2006-2012
  • Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 59: Pain Management Therapeutics Market, US, Treatment Usage Pattern (million), 2006-2012
  • Table 60: Pain Management Therapeutics Market, US, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 61: Pain Management Therapeutics Market, Top Five European Countries, Revenue ($bn), 2006-2012
  • Table 62: Pain Management Therapeutics Market, Top Five European Countries, Revenue Forecast ($bn), 2012-2019
  • Table 63: Pain Management Therapeutics Market, Top Five European Countries, Annual Cost of Therapy ($), 2006-2012
  • Table 64: Pain Management Therapeutics Market, Top Five European Countries, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 65: Pain Management Therapeutics Market, Top Five European Countries, Treatment Usage Pattern (million), 2006-2012
  • Table 66: Pain Management Therapeutics Market, Top Five European Countries, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 67: Pain Management Therapeutics Market, Japan, Revenue ($bn), 2006-2019
  • Table 68: Pain Management Therapeutics Market, Japan, Revenue Forecast ($bn), 2006-2019
  • Table 69: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2006-2012
  • Table 70: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy Forecast ($), 2012-2019
  • Table 71: Pain Management Therapeutics Market, Japan, Treatment Usage Pattern (million), 2006-2012
  • Table 72: Pain Management Therapeutics Market, Japan, Treatment Usage Pattern Forecast (million), 2012-2019
  • Table 73: Pain Management Therapeutics Market, India, Marketed Products, 2013
  • Table 74: Cipla, India, Marketed Products, 2013
  • Table 75: Sun Pharmaceuticals, India, Marketed Products, 2013
  • Table 76: Zydus Cadila, India, Marketed Products, 2013
  • Table 77: Lupin, India, Marketed Products, 2013
  • Table 78: Pain Management Therapeutics Market, China, Marketed Products, 2013
  • Table 79: Pain Management Therapeutics Market, China, Xian Janssen Marketed Products, 2013
  • Table 80: Xian Janssen, China, Marketed Products, 2013
  • Table 81: Pain Management Therapeutics Market, Australia, Marketed Products, 2013
  • Table 82: Alphapharm, Australia, Marketed Products, 2013
  • Table 83: Apotex, Australia, Marketed Products, 2013
  • Table 84: Aspen, Australia, Marketed Products, 2013
  • Table 85: Pain Management Therapeutics Market, Global, Fibromyalgia R&D Pipeline by Phase (%), 2013
  • Table 86: Pain Management Therapeutics Market, Global, Neuropathic Pain R&D Pipeline by Phase, 2013
  • Table 87: Pain Management Therapeutics Market, Global, Migraine R&D Pipeline by Phase (%), 2013
  • Table 88: Pain Management Therapeutics Market, Global, Cancer Pain R&D Pipeline by Phase, 2013
  • Table 89: Pain Management Therapeutics Market, Global, Osteoarthritis Pain R&D Pipeline by Phase (%), 2013
  • Table 90: Pain Management Therapeutics Market, Global, Low Back Pain R&D Pipeline by Phase, 2013
  • Table 91: Pain Management Therapeutics Market, Global, Post-operative Pain R&D Pipeline by Phase, 2013
  • Table 92: Pain Management Therapeutics Market, Global, Recent M&A Deals, 2011-2013
  • Table 93: Pain Management Therapeutics Market, Global, Recent Licensing Agreements, 2011-2013
  • Table 94: Pain Management Therapeutics Market, Global, Recent Partnership Deals, 2011-2013

List of Figures

  • Figure 1: Pain Management Therapeutics Market, Top Seven Markets, Revenue by Indication (%), 2012
  • Figure 2: Pain Management Therapeutics Market, WHO Three-Step Ladder for Pain Management, 2013
  • Figure 3: Pain Management Therapeutics Market, Opioids - Adverse Effects, 2013
  • Figure 4: Pain Management Therapeutics Market, Top Seven Markets, Revenue Forecast ($bn), 2006-2019
  • Figure 5: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 6: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 7: Pain Management Therapeutics Market, Drivers and Restraints, 2013
  • Figure 8: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue Forecast ($bn), 2006-2019
  • Figure 9: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 10: Pain Management Therapeutics Market, Global, Fibromyalgia, Treatment Algorithm, 2013
  • Figure 11: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 12: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Segmentation by Geography (%), 2012
  • Figure 13: Pain Management Therapeutics Market, Fibromyalgia, Drivers and Restraints, 2013
  • Figure 14: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue Forecast ($bn), 2006-2019
  • Figure 15: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 16: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Algorithm
  • Figure 17: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 18: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Segmentation by Geography (%), 2012
  • Figure 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Drivers and Restraints, 2013
  • Figure 20: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue Forecast ($bn), 2006-2019
  • Figure 21: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 22: Pain Management Therapeutics Market, Global, Migraine, Treatment Algorithm
  • Figure 23: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 24: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Segmentation by Geography (%), 2012
  • Figure 25: Pain Management Therapeutics Market, Migraine, Drivers and Restraints, 2013
  • Figure 26: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue Forecast ($bn), 2006-2019
  • Figure 27: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 28: Pain Management Therapeutics Market, Global, Cancer Pain, Treatment Algorithm
  • Figure 29: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 30: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Segmentation by Geography (%), 2012
  • Figure 31: Pain Management Therapeutics Market, Global, Cancer Pain, Drivers and Restraints, 2013
  • Figure 32: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue Forecast ($bn), 2006-2019
  • Figure 33: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 34: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Algorithm
  • Figure 35: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 36: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Segmentation by Geography (%), 2012
  • Figure 37: Pain Management Therapeutics Market, Global, Osteoarthritis Pain, Drivers and Restraints, 2013
  • Figure 38: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue Forecast ($bn), 2006-2019
  • Figure 39: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy Forecast ($'000), 2006-2019
  • Figure 40: Pain Management Therapeutics Market, Global, Rheumatoid Arthritis Pain, Treatment Algorithm
  • Figure 41: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 42: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Segmentation by Geography (%), 2012
  • Figure 43: Pain Management Therapeutics Market, Global, Rheumatoid Arthritis Pain Drivers and Restraints, 2013
  • Figure 44: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Revenue Forecast ($bn), 2006-2019
  • Figure 45: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 46: Pain Management Therapeutics Market, Global, Low Back Pain, Treatment Algorithm
  • Figure 47: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 48: Pain Management Therapeutics Market, Top Seven Markets, Low Back Pain, Segmentation by Geography (%), 2012
  • Figure 49: Pain Management Therapeutics Market, Global, Low Back Pain Drivers and Restraints, 2013
  • Figure 50: Pain Management Therapeutics Market, WFSA Three-step Ladder for Pain Management
  • Figure 51: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Revenue Forecast ($bn), 2006-2019
  • Figure 52: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 53: Pain Management Therapeutics Market, Global, Post-operative Pain Treatment Algorithm
  • Figure 54: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 55: Pain Management Therapeutics Market, Top Seven Markets, Post-operative Pain, Segmentation by Geography (%), 2012
  • Figure 56: Pain Management Therapeutics Market, Global, Post-operative Pain Drivers and Restraints, 2013
  • Figure 57: Pain Management Therapeutics Market, Top Seven Markets, Market Share by Geography (%), 2012
  • Figure 58: Pain Management Therapeutics Market, US, Revenue Forecast ($bn), 2006-2019
  • Figure 59: Pain Management Therapeutics Market, US, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 60: Pain Management Therapeutics Market, US, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 61: Pain Management Therapeutics Market, Top Five European Countries, Revenue Forecast ($bn), 2006-2019
  • Figure 62: Pain Management Therapeutics Market, Top Five European Countries, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 63: Pain Management Therapeutics Market, Top Five European Countries, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 64: Pain Management Therapeutics Market, Japan, Revenue Forecast ($bn), 2006-2019
  • Figure 65: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy Forecast ($), 2006-2019
  • Figure 66: Pain Management Therapeutics Market, Japan, Treatment Usage Pattern Forecast (million), 2006-2019
  • Figure 67: Pain Management Therapeutics Market, India, Intellectual Property Rights Protection Framework, 2011
  • Figure 68: Pain Management Therapeutics Market, India, Regulatory Landscape, Intellectual Property Rights Protection, 1963-2005
  • Figure 69: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication (%), 2013
  • Figure 70: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase (%), 2013
  • Figure 71: Pain Management Therapeutics Market, Global, Fibromyalgia R&D Pipeline by Phase (%), 2013
  • Figure 72: Pain Management Therapeutics Market, Global, Neuropathic Pain R&D Pipeline by Phase (%), 2013
  • Figure 73: Pain Management Therapeutics Market, Global, Migraine R&D Pipeline by Phase (%), 2013
  • Figure 74: Pain Management Therapeutics Market, Global, Cancer Pain R&D Pipeline by Phase (%), 2013
  • Figure 75: Pain Management Therapeutics Market, Global, Osteoarthritis Pain R&D Pipeline by Phase (%), 2013
  • Figure 76: Pain Management Therapeutics Market, Global, Low Back Pain R&D Pipeline by Phase (%), 2013
  • Figure 77: Pain Management Therapeutics Market, Global, Post-operative Pain R&D Pipeline by Phase (%), 2013
  • Figure 78: Pain Management Therapeutics Market, Global, Number of M&A Deals by Year, 2007-2013
  • Figure 79: Pain Management Therapeutics Market, Global, M&A Deals by Indication (%),2007-2013
  • Figure 80: Pain Management Therapeutics Market, Global, Number of Licensing Deals by Year, 2007-2013
  • Figure 81: Pain Management Therapeutics Market, Global, Licensing Agreements by Indication (%), 2007-2013
  • Figure 82: Pain Management Therapeutics Market, Global, Licensing Agreements by Phase (%), 2007-2013
  • Figure 83: Pain Management Therapeutics Market, Global, Number of Partnership Deals by Year, 2007-2013
  • Figure 84: Pain Management Therapeutics Market, Global, Co-Development Deals by Indication (%), 2007-2013
  • Figure 85: GBI Research Market Forecasting Model
Back to Top